After nearly three decades of serving the scientific community, Dr. Charles M. Rice and Robert M. Roth, on behalf of Apath, LLC (“Apath”), announce the conclusion of all business operations effective May 31, 2025.
 
We are deeply grateful for the opportunity to support academic, non-profit, and commercial researchers in their pursuit of scientific discovery. Since our founding, Apath’s research and development tools have played a vital role in enabling the breakthroughs that led to the cure of hepatitis C virus infections and advanced the field of virology.
 
As we close this chapter, we extend our heartfelt thanks to our dedicated employees, valued partners, scientific collaborators, and loyal customers who have been integral to our journey. Your collaboration and commitment have helped shape Apath’s legacy.
 
For any final inquiries or support needs, please contact us before May 31, 2025. After this date, we regret that we will no longer be able to provide any product or technical support.  For academic research inquiries, please contact The Rice Lab, Laboratory of Virology and Infectious Disease, The Rockefeller University.
 
Apath’s impact will endure through the scientific advancements we helped make possible. We encourage our community to continue fostering innovation and supporting one another as we look to the future.
 
With sincere appreciation,
 
Drs. Charles M. Rice and Robert M. Roth
Apath, LLC